BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35835469)

  • 1. Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis.
    Damato V; Spagni G; Monte G; Woodhall M; Jacobson L; Falso S; Smith T; Iorio R; Waters P; Irani SR; Vincent A; Evoli A
    J Neurol Neurosurg Psychiatry; 2022 Sep; 93(9):995-1000. PubMed ID: 35835469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis.
    Spagni G; Gastaldi M; Businaro P; Chemkhi Z; Carrozza C; Mascagna G; Falso S; Scaranzin S; Franciotta D; Evoli A; Damato V
    Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36270951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.
    Leite MI; Jacob S; Viegas S; Cossins J; Clover L; Morgan BP; Beeson D; Willcox N; Vincent A
    Brain; 2008 Jul; 131(Pt 7):1940-52. PubMed ID: 18515870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics Of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort.
    Huda S; Woodhall MR; Vincent A; Heckmann JM
    Muscle Nerve; 2016 Dec; 54(6):1023-1029. PubMed ID: 27105303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis.
    Rodríguez Cruz PM; Al-Hajjar M; Huda S; Jacobson L; Woodhall M; Jayawant S; Buckley C; Hilton-Jones D; Beeson D; Vincent A; Leite MI; Palace J
    JAMA Neurol; 2015 Jun; 72(6):642-9. PubMed ID: 25894002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple antibody detection in 'seronegative' myasthenia gravis patients.
    Hong Y; Zisimopoulou P; Trakas N; Karagiorgou K; Stergiou C; Skeie GO; Hao HJ; Gao X; Owe JF; Zhang X; Yue YX; Romi F; Wang Q; Li HF; Gilhus NE; Tzartos SJ
    Eur J Neurol; 2017 Jun; 24(6):844-850. PubMed ID: 28470860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.
    Park KH; Waters P; Woodhall M; Lang B; Smith T; Sung JJ; Kim KK; Lim YM; Kim JE; Kim BJ; Park JS; Lim JG; Kim DS; Kwon O; Sohn EH; Bae JS; Yoon BN; Kim NH; Ahn SW; Oh J; Park HJ; Shin KJ; Hong YH
    PLoS One; 2018; 13(3):e0193723. PubMed ID: 29518096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibody detection by a live cell-based assay in conventionally antibody-tested triple seronegative Myasthenia gravis.
    Hoffmann S; Waters P; Jacobson L; Schuelke M; Stenzel W; Ruck T; Lehnerer S; Stascheit F; Preuße C; Meisel A
    Neuromuscul Disord; 2023 Feb; 33(2):139-144. PubMed ID: 36746691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures.
    Farrugia ME; Bonifati DM; Clover L; Cossins J; Beeson D; Vincent A
    J Neuroimmunol; 2007 Apr; 185(1-2):136-44. PubMed ID: 17335909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.
    Zisimopoulou P; Evangelakou P; Tzartos J; Lazaridis K; Zouvelou V; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Frenkian Cuvelier M; Stojkovic T; DeBaets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Tzartos SJ
    J Autoimmun; 2014 Aug; 52():139-45. PubMed ID: 24373505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis.
    Kwon YN; Woodhall M; Sung JJ; Kim KK; Lim YM; Kim H; Kim JE; Baek SH; Kim BJ; Park JS; Seok HY; Kim DS; Kwon O; Park KH; Sohn E; Bae JS; Yoon BN; Kim NH; Ahn SW; Choi K; Oh J; Park HJ; Shin KJ; Lee S; Park J; Kim SH; Seok JI; Bae DW; An JY; Joo IS; Choi SJ; Nam TS; Kim S; Park KJ; Kwon KH; Waters P; Hong YH
    J Neurol; 2023 Mar; 270(3):1478-1486. PubMed ID: 36396811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies in Japanese patients with ocular myasthenia gravis.
    Nagaishi A; Narita T; Woodhall M; Jacobson L; Waters P; Irani SR; Vincent A; Matsuo H
    Muscle Nerve; 2021 Feb; 63(2):262-267. PubMed ID: 33094484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving laboratory diagnostics in myasthenia gravis.
    Gastaldi M; Scaranzin S; Businaro P; Mobilia E; Benedetti L; Pesce G; Franciotta D
    Expert Rev Mol Diagn; 2021 Jun; 21(6):579-590. PubMed ID: 33970749
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical need for clustered AChR cell-based assay testing of seronegative MG.
    Masi G; Li Y; Karatz T; Pham MC; Oxendine SR; Nowak RJ; Guptill JT; O'Connor KC
    J Neuroimmunol; 2022 Jun; 367():577850. PubMed ID: 35366559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China.
    Yang L; Maxwell S; Leite MI; Waters P; Clover L; Fan X; Zhang D; Yang C; Beeson D; Vincent A
    J Neurol Sci; 2011 Feb; 301(1-2):71-6. PubMed ID: 21131008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.
    Koneczny I; Cossins J; Waters P; Beeson D; Vincent A
    PLoS One; 2013; 8(11):e80695. PubMed ID: 24244707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-AChR, MuSK, and LRP4 antibodies coexistence: A rare and distinct subtype of myasthenia gravis from Indian subcontinent.
    Bokoliya SC; Kumar VP; Nashi S; Polavarapu K; Nalini A; Patil SA
    Clin Chim Acta; 2018 Nov; 486():34-35. PubMed ID: 30006288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to agrin in myasthenia gravis patients.
    Zhang B; Shen C; Bealmear B; Ragheb S; Xiong WC; Lewis RA; Lisak RP; Mei L
    PLoS One; 2014; 9(3):e91816. PubMed ID: 24632822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin.
    Cortés-Vicente E; Gallardo E; Martínez MÁ; Díaz-Manera J; Querol L; Rojas-García R; Illa I
    JAMA Neurol; 2016 Sep; 73(9):1099-104. PubMed ID: 27379450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AChR phosphorylation and indirect inhibition of AChR function in seronegative MG.
    Plested CP; Tang T; Spreadbury I; Littleton ET; Kishore U; Vincent A
    Neurology; 2002 Dec; 59(11):1682-8. PubMed ID: 12473752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.